Krka revenue up 10% to record EUR 1.7bn in 2022, net profit at EUR 361m
Novo Mesto, 26 January - Pharma group Krka reported on Thursday a 10% revenue increase in 2022 to EUR 1.7 billion, the highest figure to date. Sales increased in the majority of Krka's key markets and in all product and service segments. Net profit rose by 17% to EUR 361 million, show the unaudited results.
Novo Mesto
Pharma group Krka reports unaudited results for 2022.
Photo: Rasto Božič/STA
Novo Mesto
Pharma group Krka reports unaudited results for 2022.
Photo: Rasto Božič/STA
Novo Mesto
Krka CEO Jože Colarič.
Photo: Rasto Božič/STA
Novo mesto
The headquarters of drug maker Krka.
Photo: Anže Malovrh/STA
The rest of this news item is available to subscribers.
The news item consists of 2.313 characters (without spaces) or 451 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.